J&J Seeks Fed. Circ. Rehearing On Stent Patents
Johnson & Johnson asked the Federal Circuit last week to rehear its appeal of a decision in favor of Boston Scientific Corp. that deemed four J&J patents for drug-eluting stents invalid...To view the full article, register now.
Already a subscriber? Click here to view full article